News Headlines

  1. Ahead Of Opening, Enzene Expands Scope For Biomanufacturing At New Jersey Site 6/16/2025

    Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, today announced that ahead of the official opening of its biologics manufacturing facility in Hopewell, close to Princeton in New Jersey, it has expanded its plans for the site.

  2. Tufts Center Study Shows Significant Time Savings In Delivering Therapies To Patients With Thermo Fisher Scientific's Accelerator Drug Development 360° CDMO And CRO Solutions 6/16/2025

    Thermo Fisher Scientific Inc., the world leader in serving science, today announced the findings of new research by the Tufts Center for the Study of Drug Development (CSDD) demonstrating the benefits of the company’s Accelerator Drug Development 360° CDMO and CRO solutions in helping biotech and biopharma companies speed life-changing medicines to patients.1

  3. Teva And Fosun Pharma Enter Into A Strategic Partnership To Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) In Immuno-Oncology 6/16/2025

    Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, SSE: 600196, HKEX: 02196) today announced that the companies, through their respective subsidiaries, have entered a strategic partnership for the development of investigational TEV-56278, an anti-PD1-IL2 ATTENUKINE therapy.

  4. FAREVA Strengthens Its Expertise With A New GMP Sterile Pilot Unit In Pau 6/16/2025

    At its Pau site, FAREVA continues to drive pharmaceutical innovation with the opening of a new GMP sterile pilot unit dedicated to the production of liquid and lyophilized injectable forms.

  5. 64x Bio Launches AAV Apex Suite To Power The Next Generation Of Gene Therapy Manufacturing 6/16/2025

    64x Bio, a biotech company developing scalable solutions for the production of advanced therapies, today announced the launch of AAV Apex Suite, a high yield product line designed to meet one of the most urgent bottlenecks in gene therapy — manufacturing.

  6. Astrazeneca Enters Strategic Collaboration With CSPC Pharmaceuticals Focused On AI-Enabled Research 6/13/2025

    AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Limited.

  7. Ratio Therapeutics Partners With Macrocyclics For Exclusive Manufacturing And Distribution Of Its Radiopharmaceutical Chelator Platform 6/13/2025

    Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, announced today that it entered into an agreement granting Macrocyclics Inc. (Macrocyclics) exclusive manufacturing and distribution rights to Ratio's proprietary chelator Macropa™ enabling broad access worldwide.

  8. Nanoform Starts Pivotal Human Bioequivalence Studies Of Nanoenzalutamide 6/12/2025

    Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had started pivotal relative bioequivalence studies of Nanoenzalutamide, the nanocrystalline-enabled enzalutamide tablet formulation, a potential alternative to the amorphous solid dispersion (ASD) used in XTANDI® (enzalutamide) [1], the number one prescribed androgen receptor inhibitor [2] approved to treat prostate cancer.

  9. Simtra BioPharma Solutions And MilliporeSigma Announce Strategic Alliance For Antibody Drug Conjugates Drug Substance And Drug Product Manufacturing Services 6/12/2025
  10. UCB Announces Major U.S. Investment To Expand Biologics Manufacturing Capacity 6/12/2025

    UCB, a global biopharmaceutical company focused on improving the lives of people with severe diseases, today announced plans for a significant investment in a new, state-of-the-art biologics manufacturing facility in the United States.